MANNKIND CORP Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MANNKIND CORP stock issued during period, value, new issues for the quarter ending 2024-03-31 was $1.36M, a 13.51% increase year-over-year.
- MANNKIND CORP stock issued during period, value, new issues for the quarter ending 2023-09-30 was $4.11M, a 79.26% decline year-over-year.
- MANNKIND CORP stock issued during period, value, new issues for the quarter ending 2023-06-30 was $1.58M.
- MANNKIND CORP stock issued during period, value, new issues for the quarter ending 2023-03-31 was $1.20M.
- MANNKIND CORP stock issued during period, value, new issues for fiscal 2025 was $275.00K.
- MANNKIND CORP stock issued during period, value, new issues for fiscal 2023 was $6.89M, a 65.20% decline from fiscal 2022.
- MANNKIND CORP stock issued during period, value, new issues for fiscal 2022 was $19.79M, a 949.31% increase from fiscal 2021.
- MANNKIND CORP stock issued during period, value, new issues for fiscal 2021 was $1.89M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $275.00K 10-K · filed 2026-02-26 | |
| 2024-03-31 | $1.36M 10-Q · filed 2024-11-07 | |
| 2023-12-31 | $6.89M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $4.11M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $1.58M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $1.20M 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $19.79M 10-K · filed 2025-02-26 | |
| 2022-09-30 | $19.79M 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $1.89M 10-K · filed 2024-02-27 | |
| 2017-12-31 | $564.00K 10-K · filed 2018-02-27 | |
| 2015-12-31 | $27.84M 10-K · filed 2018-02-27 | |
| 2013-12-31 | $48.89M 10-K · filed 2016-03-15 | |
| 2011-12-31 | $9.54M 10-K · filed 2014-03-03 | |
| 2010-12-31 | $14.34M 10-K · filed 2014-03-03 | |
| 2009-12-31 | $59.72M 10-K · filed 2014-03-03 | |
| 2007-12-31 | $249.75M 10-K · filed 2014-03-03 | |
| 2006-12-31 | $384.67M 10-K · filed 2014-03-03 | |
| 2005-12-31 | $170.23M 10-K · filed 2014-03-03 | |
| 2004-12-31 | $83.18M 10-K · filed 2012-03-15 | |
| 2003-12-31 | $50.00M 10-K · filed 2014-03-03 | |
| 2002-12-31 | $58.81M 10-K · filed 2014-03-03 | |
| 2001-12-31 | $78.03M 10-K · filed 2014-03-03 | |
| 2000-12-31 | $31.63M 10-K · filed 2014-03-03 | |
| 1999-12-31 | $534.00K 10-K · filed 2014-03-03 | |
| 1998-12-31 | $12.73M 10-K · filed 2014-03-03 | |
| 1997-12-31 | $196.00K 10-K · filed 2014-03-03 | |
| 1996-12-31 | $59.00K 10-K · filed 2014-03-03 | |
| 1994-02-28 | $526.00K 10-K · filed 2014-03-03 | |
| 1993-02-28 | $888.00K 10-K · filed 2014-03-03 | |
| 1992-02-29 | $900.00K 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |